| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
IPAR
Inter Parfums
|
Jun 12, 2026 | BUY |
Strong Buy
+0.5% avg upside
8 analysts
|
$110.00
11.28% Upside
|
· |
|
JILL
JJill
|
Jun 11, 2026 | HOLD |
Buy
+2.7% avg upside
10 analysts
|
$14.00
4.43% Downside
|
· |
|
VSXY
Victoria's Secret
|
Jun 04, 2026 | HOLD |
Buy
-10.2% avg upside
14 analysts
|
$75.00
7.36% Downside
|
· |
|
SN
SharkNinja, Inc.
|
Jun 03, 2026 | BUY |
Strong Buy
+3.8% avg upside
14 analysts
|
$145.00
5.04% Upside
|
+16.3% |
|
GAP
Gap Inc
|
May 29, 2026 | BUY |
Strong Buy
+28.7% avg upside
31 analysts
|
$26.00
22.63% Upside
|
+1.0% |
|
AEO
American Eagle
|
May 28, 2026 | HOLD |
Hold
+7.9% avg upside
24 analysts
|
$18.00
3.21% Upside
|
· |
|
BBWI
Bath & Body Works
|
May 27, 2026 | BUY |
Hold
+55.5% avg upside
28 analysts
|
$25.00
19.19% Upside
|
· |
|
OWLT
Owlet
|
May 08, 2026 | BUY |
Strong Buy
+153.5% avg upside
10 analysts
|
$13.00
173.05% Upside
|
-15.8% |
|
BTMD
biote
|
May 07, 2026 | BUY |
Strong Buy
+108.6% avg upside
8 analysts
|
$2.50
10.09% Upside
|
-5.7% |
|
OLPX
Olaplex Holdings
|
Apr 23, 2026 | HOLD |
Hold
-3.0% avg upside
12 analysts
|
$2.06
0.33% Upside
|
+1.0% |
|
HIMS
Hims & Hers Health
|
Mar 27, 2026 | HOLD |
Buy
-22.4% avg upside
22 analysts
|
$23.00
30.58% Downside
|
+40.2% |
|
WALD
Waldencast
|
Aug 20, 2025 | HOLD |
Buy
+37.9% avg upside
6 analysts
|
$2.00
17.68% Upside
|
-13.5% |
|
CURV
Torrid Holdings
|
Sep 19, 2023 | HOLD |
Hold
+73.8% avg upside
12 analysts
|
$1.50
21.91% Downside
|
+195.2% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.